NASDAQ:APTO
Aptose Biosciences Stock News
$1.23
+0 (+0%)
At Close: May 09, 2024
Aptose Reports Results for the Fourth Quarter and Full Year 2019
08:02pm, Tuesday, 10'th Mar 2020
Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated agents that target the underlying mechanisms of cancer,
Daqo New Energy (DQ) to Post Q4 Earnings: What's in Store?
12:00am, Friday, 06'th Mar 2020Analysts Are Bullish on Top Healthcare Stocks: ACADIA Pharmaceuticals (ACAD), Aptose Biosciences (APTO)
11:41am, Thursday, 27'th Feb 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ACADIA Pharmaceuticals (ACAD) and Aptose Biosciences (APTO)
Aptose to Release Fourth Quarter and Year End December 31, 2019 Financial Results and Hold Conference Call on March 10, 2020
12:31pm, Tuesday, 25'th Feb 2020
SAN DIEGO and TORONTO, Feb. 25, 2020 -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the.
AMD, STM among premarket losers
02:17pm, Monday, 24'th Feb 2020
Ballard Power Systems (NASDAQ:BLDP) -15%.DPW Holdings (NYSEMKT:DPW) -10%.Plug Power (NASDAQ:PLUG) -10%.Virgin Galactic Holdings (NYSE:SPCE) -10%.FuelCell Energy (NASDAQ:FCEL) -9%.JinkoSolar Holding (
The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion
12:46pm, Friday, 21'st Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 20.) Akebia Therapeutics Inc (NASDAQ: AKBA ) Aptose B
Are Options Traders Betting on a Big Move in Aptose (APTO) Stock?
12:00am, Friday, 21'st Feb 2020's Top Upgrades, Downgrades For February 20, 2020
03:05pm, Thursday, 20'th Feb 2020
Upgrades
Stifel Nicolaus upgraded La-Z-Boy Incorporated (NYSE: LZB) from Hold to Buy. La-Z-Boy shares closed at $32.76 on Wednesday.
Citigroup upgraded Analog Devices, Inc...
Maxim Group Initiates Coverage On Aptose Biosciences with Buy Rating, Announces $16 Price Target
12:00am, Thursday, 20'th Feb 2020The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA
12:21pm, Wednesday, 19'th Feb 2020
Here's a roundup of top developments in the … Full story available on Benzinga.com
Opaleye Management Inc. Buys Aptose Biosciences Inc, Ocular Therapeutix Inc, Intra-Cellular ...
12:00am, Monday, 17'th Feb 2020Could This Cancer Drug Developer’s Stock Make You Rich?
03:15pm, Friday, 14'th Feb 2020
Investing in this emerging cancer-focused biotech may just allow you to retire early.
